These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3056241)

  • 21. Comparative in vitro activities of 20 fluoroquinolones against Mycobacterium leprae.
    Franzblau SG; White KE
    Antimicrob Agents Chemother; 1990 Feb; 34(2):229-31. PubMed ID: 2183714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening of drugs for activity against Mycobacterium leprae.
    Baohong J; Matsuo Y; Colston MJ
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4 Suppl):836-42. PubMed ID: 3325576
    [No Abstract]   [Full Text] [Related]  

  • 23. The influence of structural modifications of dihydrophenazines on arachidonic acid mobilization and superoxide generation by human neutrophils.
    Zeis BM; Savage J; O'Sullivan JF; Anderson R
    Lepr Rev; 1990 Jun; 61(2):163-70. PubMed ID: 2165549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dapsone drug resistance in the MDT era.
    Roche PW; Neupane KD; Failbus SS; Butlin CR
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097
    [No Abstract]   [Full Text] [Related]  

  • 25. Inhibition of phenolic glycolipid-I synthesis in extracellular Mycobacterium leprae as an indicator of antimicrobial activity.
    Harris EB; Franzblau SG; Hastings RC
    Int J Lepr Other Mycobact Dis; 1988 Dec; 56(4):588-91. PubMed ID: 3065422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of ATP assay for in vitro drug screening testing against human derived M. leprae.
    Katoch VM; Katoch K; Shivannavar CT; Sharma VD; Patil MA; Bharadwaj VP
    Indian J Lepr; 1989 Jul; 61(3):333-44. PubMed ID: 2671179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel tetramethylpiperidine-substituted phenazines are potent inhibitors of P-glycoprotein activity in a multidrug resistant cancer cell line.
    Van Rensburg CE; Anderson R; Jooné G; Myer MS; O'Sullivan JF
    Anticancer Drugs; 1997 Aug; 8(7):708-13. PubMed ID: 9311448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Double-blind evaluation of BACTEC and Buddemeyer-type radiorespirometric assays for in vitro screening of antileprosy agents.
    Franzblau SG; Biswas AN; Jenner P; Colston MJ
    Lepr Rev; 1992 Jun; 63(2):125-33. PubMed ID: 1640779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of ten phenazine-derivatives in comparison to clofazimine on the production of prostaglandin E2 by polymorphonuclear leucocytes.
    Zeis BM; Anderson R; O'Sullivan JF
    Lepr Rev; 1987 Dec; 58(4):383-8. PubMed ID: 3481012
    [No Abstract]   [Full Text] [Related]  

  • 30. A rapid, microplate-based assay for evaluating the activity of drugs against Mycobacterium leprae, employing the reduction of Alamar Blue.
    Franzblau S
    Lepr Rev; 2000 Dec; 71 Suppl():S74-5; discussion S76. PubMed ID: 11201892
    [No Abstract]   [Full Text] [Related]  

  • 31. A Mycobacterium leprae isolate resistant to dapsone, rifampin, ofloxacin and sparfloxacin.
    Matsuoka M; Kashiwabara Y; Namisato M
    Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):452-5. PubMed ID: 11332288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of mutations in folp1, rpoB and gyrA genes of M. leprae by PCR- direct sequencing--a rapid tool for screening drug resistance in leprosy.
    Sekar B; Arunagiri K; Kumar BN; Narayanan S; Menaka K; Oommen PK
    Lepr Rev; 2011 Mar; 82(1):36-45. PubMed ID: 21644470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The "proportional bactericidal test": a method for assessing bactericidal activity in drugs against Mycobacterium leprae in mice.
    Colston MJ; Hilson GR; Banerjee DK
    Lepr Rev; 1978 Mar; 49(1):7-15. PubMed ID: 347206
    [No Abstract]   [Full Text] [Related]  

  • 34. Activity of four clofazimine analogues against Mycobacterium leprae.
    Levy L
    Lepr Rev; 1981 Mar; 52(1):23-6. PubMed ID: 7017318
    [No Abstract]   [Full Text] [Related]  

  • 35. Prooxidative activities of 10 phenazine derivatives relative to that of clofazimine.
    Zeis BM; Anderson R; O'Sullivan JF
    Antimicrob Agents Chemother; 1987 May; 31(5):789-93. PubMed ID: 3038009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid in vitro metabolic screen for antileprosy compounds.
    Franzblau SG; Hastings RC
    Antimicrob Agents Chemother; 1987 May; 31(5):780-3. PubMed ID: 3300539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid detection of resistance to rifampicin in Mycobacterium leprae.
    Roche PW; Shrestha N; Thomas A; Honore N; Cole ST
    Lepr Rev; 2000 Dec; 71 Suppl():S96-7; discussion S97-9. PubMed ID: 11201897
    [No Abstract]   [Full Text] [Related]  

  • 38. Statistical analysis of results obtained by two methods for testing drug activity against Mycobacterium leprae.
    Shepard CC
    Int J Lepr Other Mycobact Dis; 1982 Mar; 50(1):96-101. PubMed ID: 7042616
    [No Abstract]   [Full Text] [Related]  

  • 39. Multidrug therapy (MDT) and leprosy control.
    Noordeen SK
    Indian J Lepr; 1990; 62(4):448-58. PubMed ID: 2086680
    [No Abstract]   [Full Text] [Related]  

  • 40. Clofazimine-resistant M. leprae.
    Levy L
    Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):137-40. PubMed ID: 3519801
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.